Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5397
-0.0556 %
$ 23 M
Market Cap
-3.17
P/E
ADAP - OTHER CURRENT ASSETS
Other Current Assets ADAP - Adaptimmune Therapeutics plc
13.7 M
LAST VALUE
-49.72%
2 YEAR CAGR
-15.64%
5 YEAR CAGR
25.91%
10 YEAR CAGR